Hyderabad prepares for a major global announcement. Chief Minister A Revanth Reddy will present the Telangana Next-Gen Life Sciences Policy 2026-2030 at the World Economic Forum in Davos on January 20. This policy outlines an ambitious target. Telangana aims to build a massive $250 billion life sciences economy by the year 2030.
Building on a Strong Foundation
Telangana already holds a powerful position in the pharmaceutical world. The state accounts for nearly 40% of India's total pharmaceutical production. It has earned the title 'vaccine capital of the world' by producing one-third of global vaccines. Hyderabad hosts major global companies like Eli Lilly, Sanofi, MSD, Novartis, Amgen, and BMS. Over 2,000 life sciences companies operate here with a combined valuation of $80 billion. More than 250 manufacturing sites have approval from the USFDA.
The new policy seeks to consolidate this strong manufacturing base. It will accelerate the state's transition into a hub for advanced research and development. Chief Minister Revanth Reddy has positioned Telangana for a larger leadership role. The goal is to shape the future of global healthcare and life sciences innovation.
The Green Pharma City Vision
A senior official explained the strategic roadmap. "Telangana is building a world-class, sustainable industrial cluster," the official said. This cluster is designed to transform pharmaceutical manufacturing and R&D. The policy will unveil plans for the development of Green Pharma City.
This project is part of the larger Bharat Future City initiative. It is strategically located near the international airport. The location offers seamless connectivity to major industrial zones, including an emerging AI hub. Green Pharma City combines advanced infrastructure with environmentally friendly practices.
The project features zero liquid discharge, centralized waste management, and energy-efficient systems. It has been meticulously designed around a 'work, live, learn, and play' philosophy. This ensures a world-class ecosystem for professionals and researchers.
A Global Integration Strategy
The global life sciences sector is undergoing rapid change. Advanced therapies, data-driven discovery, precision medicine, and sustainability are reshaping the industry. Officials stated that Telangana aims to move beyond mere scale. The state wants to lead through value, innovation, and deeper global integration.
The Next-Gen policy has a clear target. It aims to position Telangana among the top three global life sciences clusters by 2030. The focus will be on developing frontier capabilities. "Green Pharma City and flagship pharma villages will reinforce Telangana's position as a global hub," an official from the Chief Minister's Office said.
Hyderabad is also home to the World Economic Forum's Centre for the Fourth Industrial Revolution. This adds to the city's innovative credentials. Another key initiative is the '1Bio' facility. It is a first-of-its-kind growth phase centre and biopharma scale-up manufacturing facility located in Genome Valley, Hyderabad.
Driving Collaboration and Growth
Telangana Global Life Sciences serves as the flagship platform for this vision. It connects global leaders, investors, researchers, and policymakers. The platform showcases the state's innovation ecosystem. It drives high-value collaborations to support the $250 billion economy goal.
The state's success is supported by several key factors. Robust infrastructure, progressive policies, a cluster-based ecosystem, and a strong talent pool form the backbone. Hyderabad has over 20 life sciences and medtech incubators anchoring this globally competitive sector.
Together, the Telangana Next-Gen Life Sciences Policy 2026-2030 represents a powerful statement of intent. It positions the state to shape the next chapter in global life sciences and healthcare innovation. The unveiling at Davos marks a significant step in this strategic journey.
